• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者肾功能不全的流行病学及重要性

Epidemiology and importance of renal dysfunction in heart failure patients.

作者信息

Giamouzis Gregory, Kalogeropoulos Andreas P, Butler Javed, Karayannis Georgios, Georgiopoulou Vasiliki V, Skoularigis John, Triposkiadis Filippos

机构信息

Heart Failure Unit, Cardiology Department, Larissa University Hospital, P.O. Box 1425, 411 10, Larissa, Greece,

出版信息

Curr Heart Fail Rep. 2013 Dec;10(4):411-20. doi: 10.1007/s11897-013-0164-6.

DOI:10.1007/s11897-013-0164-6
PMID:24097112
Abstract

Renal dysfunction (RD) is a frequent comorbid condition and a major determinant of outcomes in patients with heart failure (HF). It is likely that the etiology of RD in patients with HF is much more complex than we first thought and represents a matrix of independent, albeit interacting, pathophysiological pathways with effects on both the kidney and the heart that share a common denominator: aging and inflammation. Renal dysfunction in HF has been attributed, among others, to biochemical, hormonal, and hemodynamic factors, coupled with pharmacological interventions. Regardless of the cause, the development of RD or worsening renal function is common in patients with HF, and is associated with increased morbidity and mortality. There is increasing evidence, however, that transient increases in creatinine in the setting of acute HF are not prognostically important, whereas persistent deterioration does portend a higher mortality in this patient population. In addition, congestion seems to play an important role in the course of renal deterioration, and the combination of congestion and worsening renal function is the most significant clinical prognosticator in HF patients. This review aims to provide an update on the epidemiology and prognostic significance of RD in HF patients, in both the acute and the chronic setting.

摘要

肾功能不全(RD)是一种常见的合并症,也是心力衰竭(HF)患者预后的主要决定因素。心力衰竭患者肾功能不全的病因可能比我们最初认为的要复杂得多,它代表了一系列独立但相互作用的病理生理途径,这些途径对肾脏和心脏都有影响,其共同特征是衰老和炎症。心力衰竭患者的肾功能不全除其他因素外,还归因于生化、激素和血流动力学因素,以及药物干预。无论病因如何,肾功能不全的发生或肾功能恶化在心力衰竭患者中很常见,并且与发病率和死亡率增加相关。然而,越来越多的证据表明,急性心力衰竭时肌酐的短暂升高在预后方面并不重要,而持续恶化确实预示着该患者群体的死亡率更高。此外,充血似乎在肾脏恶化过程中起重要作用,充血和肾功能恶化的组合是心力衰竭患者最重要的临床预后指标。本综述旨在提供关于急性和慢性心力衰竭患者肾功能不全的流行病学及预后意义的最新信息。

相似文献

1
Epidemiology and importance of renal dysfunction in heart failure patients.心力衰竭患者肾功能不全的流行病学及重要性
Curr Heart Fail Rep. 2013 Dec;10(4):411-20. doi: 10.1007/s11897-013-0164-6.
2
A combined-biomarker approach to clinical phenotyping renal dysfunction in heart failure.一种用于心力衰竭患者肾功能不全临床表型分析的联合生物标志物方法。
J Card Fail. 2014 Dec;20(12):912-9. doi: 10.1016/j.cardfail.2014.08.008. Epub 2014 Aug 23.
3
Renal dysfunction in heart failure.心力衰竭中的肾功能障碍。
Med Clin North Am. 2012 Sep;96(5):955-74. doi: 10.1016/j.mcna.2012.07.005.
4
Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment.急性心力衰竭中的肾功能障碍:流行病学、机制和评估。
Heart Fail Rev. 2012 Mar;17(2):271-82. doi: 10.1007/s10741-011-9265-z.
5
The impact of kidney dysfunction categorized by urinary to serum creatinine ratio on clinical outcomes in patients with heart failure.根据尿肌酐与血清肌酐比值分类的肾功能不全对心力衰竭患者临床结局的影响。
Heart Vessels. 2020 Feb;35(2):187-196. doi: 10.1007/s00380-019-01472-4. Epub 2019 Jul 22.
6
The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?心力衰竭中的心肾综合征:心源性?肾源性?综合征?
Heart Fail Rev. 2012 May;17(3):355-66. doi: 10.1007/s10741-011-9291-x.
7
Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigations.肾功能障碍对心力衰竭住院患者预后的影响:来自过去十年临床研究的数据。
Heart Fail Rev. 2013 Mar;18(2):167-76. doi: 10.1007/s10741-012-9317-z.
8
Renal function in advanced heart failure.晚期心力衰竭患者的肾功能
Congest Heart Fail. 2011 Jul-Aug;17(4):180-8. doi: 10.1111/j.1751-7133.2011.00240.x. Epub 2011 Jul 21.
9
Heart failure and kidney dysfunction: epidemiology, mechanisms and management.心力衰竭与肾脏功能障碍:流行病学、发病机制与治疗。
Nat Rev Nephrol. 2016 Oct;12(10):610-23. doi: 10.1038/nrneph.2016.113. Epub 2016 Aug 30.
10
Changes in renal function in congestive heart failure.充血性心力衰竭时肾功能的变化
Curr Heart Fail Rep. 2013 Dec;10(4):285-95. doi: 10.1007/s11897-013-0170-8.

引用本文的文献

1
Analyzing Insights of Super-Response in Cardiac Resynchronization Therapy with Fusion Pacing.分析融合起搏心脏再同步治疗中超级反应的见解。
Diagnostics (Basel). 2025 Apr 28;15(9):1118. doi: 10.3390/diagnostics15091118.
2
Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits.推进心力衰竭的指南导向医学治疗:克服挑战并最大化获益。
Am J Cardiovasc Drugs. 2024 May;24(3):329-342. doi: 10.1007/s40256-024-00646-4. Epub 2024 Apr 3.
3
The Interplay of Comorbidities in Chronic Heart Failure: Challenges and Solutions.

本文引用的文献

1
Abdominal contributions to cardiorenal dysfunction in congestive heart failure.充血性心力衰竭中心肾功能障碍的腹部贡献。
J Am Coll Cardiol. 2013 Aug 6;62(6):485-95. doi: 10.1016/j.jacc.2013.04.070. Epub 2013 Jun 7.
2
Venous congestion and renal function in heart failure ... it's complicated.心力衰竭中的静脉充血与肾功能……情况很复杂。
Eur J Heart Fail. 2013 Jun;15(6):599-601. doi: 10.1093/eurjhf/hft060. Epub 2013 Apr 19.
3
Protection of renal impairment by angiotensin II type 1 receptor blocker in rats with post-infarction heart failure.
慢性心力衰竭合并症的相互作用:挑战与解决方案。
Curr Cardiol Rev. 2024;20(3):13-29. doi: 10.2174/011573403X289572240206112303.
4
Prevalence, correlates and in-hospital outcomes of kidney dysfunction in hospitalized patients with heart failure in Buea-Cameroon.喀麦隆布埃亚-住院心力衰竭患者肾功能障碍的流行情况、相关因素和院内结局。
BMC Nephrol. 2022 Jan 3;23(1):8. doi: 10.1186/s12882-021-02641-2.
5
Effects of dual blockade in heart failure and renal dysfunction: Systematic review and meta-analysis.心力衰竭和肾功能障碍双重阻断的效果:系统评价和荟萃分析。
J Renin Angiotensin Aldosterone Syst. 2019 Oct-Dec;20(4):1470320319882656. doi: 10.1177/1470320319882656.
6
The impact of kidney dysfunction categorized by urinary to serum creatinine ratio on clinical outcomes in patients with heart failure.根据尿肌酐与血清肌酐比值分类的肾功能不全对心力衰竭患者临床结局的影响。
Heart Vessels. 2020 Feb;35(2):187-196. doi: 10.1007/s00380-019-01472-4. Epub 2019 Jul 22.
7
Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.血管紧张素转换酶阻断单独或联合可溶性环氧化物水解酶阻断对伴有主动脉-腔静脉瘘的Ren-2转基因高血压大鼠充血性心力衰竭病程及肾功能障碍发生的影响。
Physiol Res. 2018 Jul 17;67(3):401-415. doi: 10.33549/physiolres.933757. Epub 2018 Mar 12.
8
Response and outcomes of cardiac resynchronization therapy in patients with renal dysfunction.肾功能不全患者心脏再同步治疗的反应及结果
J Interv Card Electrophysiol. 2018 Apr;51(3):237-244. doi: 10.1007/s10840-018-0330-6. Epub 2018 Feb 19.
9
Plasma Nitration of High-Density and Low-Density Lipoproteins in Chronic Kidney Disease Patients Receiving Kidney Transplants.接受肾移植的慢性肾病患者中高密度脂蛋白和低密度脂蛋白的血浆硝化作用
Mediators Inflamm. 2015;2015:352356. doi: 10.1155/2015/352356. Epub 2015 Nov 15.
10
Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.抑制可溶性环氧化物水解酶并不能改善由主动脉-腔静脉瘘引起的容量超负荷大鼠的充血性心力衰竭病程及肾功能障碍的发展。
Physiol Res. 2015;64(6):857-73. doi: 10.33549/physiolres.932977. Epub 2015 Jun 5.
血管紧张素 II 型 1 型受体阻滞剂对梗死后心力衰竭大鼠肾损害的保护作用。
Ren Fail. 2013;35(5):766-75. doi: 10.3109/0886022X.2013.780561. Epub 2013 Apr 8.
4
The relation between decreased glomerular filtration rate and nonvalvular atrial fibrillation.肾小球滤过率降低与非瓣膜性心房颤动之间的关系。
Cardiology. 2013;124(4):219. doi: 10.1159/000347137. Epub 2013 Mar 29.
5
Fluid loss, venous congestion, and worsening renal function in acute decompensated heart failure.急性失代偿性心力衰竭中的液体流失、静脉充血和肾功能恶化。
Eur J Heart Fail. 2013 Jun;15(6):637-43. doi: 10.1093/eurjhf/hft036. Epub 2013 Mar 8.
6
Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score.预测接受连续血流左心室辅助装置治疗的患者的生存率:HeartMate II 风险评分。
J Am Coll Cardiol. 2013 Jan 22;61(3):313-21. doi: 10.1016/j.jacc.2012.09.055. Epub 2012 Dec 19.
7
Renal dysfunction in heart failure.心力衰竭中的肾功能障碍。
Med Clin North Am. 2012 Sep;96(5):955-74. doi: 10.1016/j.mcna.2012.07.005.
8
Prognostic value of serum cystatin C and N-terminal pro b-type natriuretic peptide in patients with acute heart failure.血清胱抑素 C 和 N 末端 pro B 型利钠肽在急性心力衰竭患者中的预后价值。
Eur J Intern Med. 2012 Oct;23(7):599-603. doi: 10.1016/j.ejim.2012.06.002. Epub 2012 Jun 22.
9
Phosphodiesterase 5 inhibition protects against increased intra-abdominal pressure-induced renal dysfunction in experimental congestive heart failure.磷酸二酯酶 5 抑制可预防实验性充血性心力衰竭中腹腔内压升高引起的肾功能障碍。
Eur J Heart Fail. 2012 Oct;14(10):1104-11. doi: 10.1093/eurjhf/hfs102. Epub 2012 Jun 27.
10
The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction.PROTECT 院内风险模型:合并急性心力衰竭和肾功能障碍住院患者的 7 天结局。
Eur J Heart Fail. 2012 Jun;14(6):605-12. doi: 10.1093/eurjhf/hfs029. Epub 2012 Apr 25.